Go Pro

Pacer Advisors Inc. Purchases 47,729 Shares of Healthpeak Properties, Inc. $DOC

Healthpeak Properties logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Pacer Advisors increased its Healthpeak Properties (NYSE: DOC) position by 87.2% in the first quarter, purchasing 47,729 shares and bringing its total holdings to 102,445 shares valued at approximately $1.68 million. Institutional investors and hedge funds own 93.57% of the stock.
  • Analyst sentiment remains cautious: DOC has a consensus “Hold” rating from MarketBeat, with four Buy ratings and 15 Holds, while the average price target is $20.97.
  • Healthpeak exceeded quarterly expectations, reporting $0.08 in EPS versus a $0.03 consensus estimate and $771.58 million in revenue, up 11.1% year over year. The company also declared a monthly dividend of $0.1017 per share, representing an indicated yield of about 5.7%.
  • MarketBeat previews top five stocks to own in September.

Pacer Advisors Inc. raised its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 87.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 102,445 shares of the real estate investment trust's stock after buying an additional 47,729 shares during the quarter. Pacer Advisors Inc.'s holdings in Healthpeak Properties were worth $1,683,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in DOC. Advocate Investing Services LLC acquired a new stake in shares of Healthpeak Properties during the 4th quarter worth approximately $26,000. WPG Advisers LLC raised its position in Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust's stock valued at $26,000 after purchasing an additional 1,197 shares in the last quarter. CYBER HORNET ETFs LLC bought a new stake in Healthpeak Properties during the second quarter worth $33,000. Clearstead Advisors LLC boosted its holdings in shares of Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock valued at $31,000 after purchasing an additional 1,216 shares in the last quarter. Finally, Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties in the 4th quarter valued at $31,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total value of $213,736.05. Following the completion of the transaction, the insider directly owned 7,636 shares of the company's stock, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.23% of the company's stock.

Analysts Set New Price Targets

A number of research firms have recently commented on DOC. Weiss Ratings reissued a "hold (c)" rating on shares of Healthpeak Properties in a report on Wednesday. BMO Capital Markets raised their price objective on Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, June 15th. Raymond James Financial initiated coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They issued a "market perform" rating for the company. Evercore downgraded shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 price target for the company. in a research note on Monday, May 11th. Finally, Scotiabank boosted their price objective on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock a "sector perform" rating in a research note on Wednesday, May 27th. Four investment analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $20.97.

Read Our Latest Report on Healthpeak Properties

Healthpeak Properties Stock Performance

NYSE:DOC opened at $21.37 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 2.96 and a current ratio of 3.02. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The company has a 50 day simple moving average of $21.20 and a two-hundred day simple moving average of $18.80. The company has a market capitalization of $14.73 billion, a PE ratio of 61.07, a P/E/G ratio of 3.31 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company had revenue of $771.58 million for the quarter, compared to analyst estimates of $725.64 million. During the same period in the prior year, the firm posted $0.46 EPS. The company's quarterly revenue was up 11.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.76 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 5.7%. The ex-dividend date is Monday, September 14th. Healthpeak Properties's dividend payout ratio (DPR) is presently 348.57%.

About Healthpeak Properties

(Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Featured Articles

Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

Institutional Ownership by Quarter for Healthpeak Properties (NYSE:DOC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Healthpeak Properties Right Now?

Before you consider Healthpeak Properties, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.

While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines